Short-Term, Intensive Chemoresection vs Standard Adjuvant Intravesical Instillations in Non–Muscle-Invasive Bladder Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The DaBlaCa-13 Study: Short-Term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non–Muscle-Invasive Bladder Cancer—A Randomised Controlled Trial
Eur Urol 2020 Jul 28;[EPub Ahead of Print], MS Lindgren, P Bue, N Azawi, L Blichert-Refsgaard, MO Sundelin, L Dyrskjøt, JB JensenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.